Drug intelligence / Profile preview

Poltechnet

Development stage
Unknown
Lead developer
National Centre for Nuclear Research
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Poltechnet is a molybdenum-99/technetium-99m (99-Mo/99m-Tc) radionuclide generator used for the production of sodium pertechnetate (99mTc) injection, a primary tool in diagnostic nuclear medicine imaging. Developed and manufactured by the National Centre for Nuclear Research (POLATOM) in Poland and distributed by WIIK Pharma, the generator utilizes a column chromatography system where the parent isotope, molybdenum-99, decays into the metastable technetium-99m. Technetium-99m is a gamma-emitting radionuclide with a 6-hour half-life, making it ideal for various imaging procedures, either through direct injection of the eluate or by labeling specific radiopharmaceutical kits. The product is authorized for diagnostic use in Denmark and Sweden and is available in various activity levels.

Brand names
Poltechnet
Other names
99-Mo/99m-Tc generatorMolybdenum-99/Technetium-99m generator

Beyond the preview

Go deeper on Poltechnet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poltechnet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call